IMSI and Abnormal Sperm Morphology: What to Ask Before You Agree

If a semen analysis reports abnormal sperm morphology, IMSI (intracytoplasmic morphologic sperm injection) often comes up as an option. It is a variant of ICSI in which the embryologist selects sperm at very high magnification before injecting a single sperm into an egg. The practical question is not whether IMSI sounds more precise, but whether it adds anything for your particular case, and what you should confirm before paying for it.

The short answer: abnormal morphology alone is not a clear reason to choose IMSI. The evidence reviewed by the UK fertility regulator, the HFEA, is not strong enough to show that IMSI improves the chance of having a baby compared with standard ICSI, including in male-factor infertility, and that review did not support using IMSI over standard ICSI. That does not make IMSI forbidden or pointless in every situation, but it does mean the decision should rest on a specific clinical reason and an honest conversation about uncertainty, not on the promise of a better result.

What IMSI actually changes

Standard ICSI already involves choosing a sperm to inject. IMSI changes the magnification used for that choice: the HFEA describes IMSI as selecting sperm for ICSI using microscopy above 6000x magnification. The idea is that a more detailed view of sperm shape might help the embryologist avoid sperm with subtle abnormalities.

Two things follow from this. First, IMSI is not a different fertility treatment in the way that, say, a frozen versus fresh transfer is; it is a laboratory selection step layered onto ICSI. Second, the benefit, if any, would come from better sperm selection, so the relevant questions are about what is being selected, how, and whether that selection has been shown to matter for outcomes.

If you are still deciding between ICSI and conventional insemination, a separate comparison of ICSI versus standard IVF is a more useful starting point than IMSI, because IMSI only becomes relevant once ICSI is already on the table.

What the evidence does and does not show

It is worth being precise about the strength of the evidence, because clinics sometimes present IMSI as an upgrade without saying how uncertain the benefit is.

• What is established: IMSI is a high-magnification method of selecting sperm for ICSI.
• What is not established: that IMSI improves the chance of a live birth compared with standard ICSI, including for couples whose infertility is attributed to the male partner.
• What the regulator concluded: the reviewed evidence did not support using IMSI over standard ICSI.

This matters for how you read a clinic’s enthusiasm. A clinic may offer IMSI because it has the equipment and believes in the approach, which is not the same as having evidence that it works better for you. When someone recommends IMSI for abnormal morphology, a fair question is: what specific evidence or local experience supports that recommendation in my case, and what would happen if we used standard ICSI instead?

Morphology is also only one part of a semen analysis. Sperm count, movement and shape are usually read together, and a single abnormal morphology figure can be misleading if it is looked at in isolation. The guide to reading a semen analysis as one picture explains why the whole result, and how it was measured, matters.

Clinical indication: questions for your clinician

These are questions for a licensed clinician who has your records, not something a coordination service can answer. Ask them directly, and ask for the reasoning rather than only the recommendation.

1. Does my morphology result, on its own, justify IMSI? If the answer is yes, ask what threshold or finding is driving that, and whether the same conclusion would apply if my other semen parameters were different.
2. Would standard ICSI be a reasonable alternative in my case? If so, what would we lose by choosing it?
3. Does a history of poor fertilisation or previous cycle failure change the recommendation? Prior outcomes can matter clinically, so ask whether they do here and why.
4. Does sperm DNA fragmentation testing change the picture? If fragmentation has been measured or is being considered, ask how, if at all, it would affect the choice between IMSI and standard ICSI. Do not assume a high result automatically points to IMSI.
5. What are this clinic’s own outcomes with IMSI compared with standard ICSI? Ask what they measure, over what period, and whether the numbers are audited. Treat any figure as context for a conversation, not a prediction for you.
6. What are the risks and limits? Ask about anything that could go wrong or be wasted, including cycles where no suitable sperm are found or where the selection step does not change the outcome.

If you are weighing IMSI against another add-on such as MACS, the comparison of MACS versus IMSI sperm selection sets out the decision criteria side by side. Neither should be treated as proven superior.

Laboratory questions: who does it and how is it recorded

IMSI depends on equipment and on the embryologist using it. Because the technique is only as good as its execution, ask about the laboratory rather than only the clinic’s brand.

• Is IMSI performed in-house, or is any part of the process outsourced? If outsourced, where and by whom?
• Who performs the selection, and how much experience do they have with high-magnification ICSI?
• How is the selection documented in the lab record, and will that record be available to you or a future clinic?
• What happens if the sample on the day does not yield sperm that meet the selection criteria?
• Does using IMSI change the timing of the cycle, the embryology schedule, or how embryos are assessed afterwards?

These are practical questions a coordinator can help you put in writing and send to the hospital, but the answers must come from the clinical and laboratory team.

Cost, quotes and planning

IMSI is usually charged as an addition to ICSI, so the useful exercise is comparing what each quote includes, not just the headline number. Ask for the incremental fee for IMSI, and whether it is charged per cycle, per attempt, or only when the selection is actually performed.

Then check the surrounding items, because a lower IMSI fee can sit inside a quote that excludes something you will need:

• Is standard ICSI included, and is IMSI listed separately?
• Are embryology, laboratory and monitoring fees itemised?
• If PGT is being planned, does IMSI change the embryo-selection plan, the biopsy timing or the PGT quote? Ask the clinician and the laboratory, since this is a clinical and laboratory question, not a billing one.
• What is refundable or transferable if the cycle is cancelled or the selection step is not used?
• Are there charges for records, reports or follow-up communication after you return home?

Mark every field the hospital has not confirmed. A quote with clear gaps is more useful than one that looks complete but leaves the inclusions vague.

A worked planning sequence

Suppose your semen analysis shows abnormal morphology and you are researching clinics in Thailand. A practical order of work looks like this:

1. Collect the records. Gather the full semen analysis reports, any repeat tests, and any prior cycle summaries, with dates. Note which laboratory produced each result and whether the same method was used.
2. Write the clinical questions first. Use the list above, adapted to your history, and send them before any consultation so the clinician can review the records.
3. Ask for a remote consultation. Request the format, the records the clinic wants in advance, the time zone, and whether a fee applies. Confirm these in writing.
4. Request itemised quotes from more than one clinic. Compare the same inclusions across quotes, and keep a column for unconfirmed items.
5. Plan the Thailand arrangements only after the clinical plan is clear. Appointment location, travel dependencies and language support should follow a confirmed plan, not precede it.
6. Agree the return-home handoff. Before you travel, decide who will receive your records, in what format, and which follow-up questions you want answered after the cycle.

If you are at an earlier stage and want the broader picture of male-factor diagnosis and options, the guide to male factor infertility in Thailand covers the diagnostic pathway, and the questions to ask before planning are collected in male factor infertility and PGT planning questions.

Where coordination helps, and where it stops

A coordination service can help you organise records, draft and send questions, request appointments and remote consultations, plan travel around confirmed appointments, and arrange a records handover after you return home. It cannot tell you whether IMSI is clinically indicated for you, interpret your semen analysis, or predict your chances. Those answers belong to licensed clinicians, and the decision about whether to add IMSI should be made with them, with the uncertainty in the evidence stated plainly.

If you would like help preparing a question list and comparing what each quote includes, you can request a case review and we will set out what is confirmed and what still needs a clinical answer.

Frequently asked questions

Does abnormal sperm morphology mean I need IMSI?

Not automatically. Abnormal morphology is one finding among several in a semen analysis, and the reviewed evidence does not show that IMSI improves the chance of a baby compared with standard ICSI, including in male-factor infertility. Ask your clinician whether there is a specific reason in your history that would justify IMSI, and what standard ICSI would mean for you.

Is IMSI the same as ICSI?

No. ICSI is the injection of a single sperm into an egg. IMSI is a way of selecting that sperm using microscopy above 6000x magnification before injection, so it is a laboratory selection step added to ICSI rather than a separate treatment.